Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression

Conclusions Afro-Caribbean patients with OAG at risk for progression can achieve clinically and statistically significant reductions in IOP or medications through up to 24 months following a single 360° SLT treatment. Trial registration number NCT02375009.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Original articles - Clinical science Source Type: research